ICTHIC 2026 Topics
The aim of ICTHIC is to review the recent advances in the understanding of the pathogenesis, prevention and treatment of thrombotic and hemorrhagic complications in cancer patients, both from the basic and clinical research points of view.
The major topics of the conference are:
- Anticoagulant Treatment (VTE, ATE)
- Anticoagulant Primary Prophylaxis
- Antithrombotic Drugs
- Arterial Thrombosis
- Bleeding Issues
- Complement-driven Thrombotic Syndromes
- Congenital and Acquired Risk Factors
- Disseminated Intravascular Coagulation (DIC)
- Drug-Drug Interactions
- Epidemiology
- Fibrinolysis
- Gender- and Age-related Issues
- Hemostasis in Cancer Biology
- Heparin-induced thrombotic (HIT)
- Hypercoagulation and Biomarkers
- Immunotherapy and Target Therapy related VTE
- Inflammation
- Laboratory Assays for Hypercoagulability
- Mechanisms of Thrombosis and Bleeding in Cancer
- Microangiopathies
- Microparticles
- Proteases
- Role of Antithrombotics in Cancer Survival
- Thrombocytopenias
- Thrombotic complications post BMT
- Thrombotic complications post CAR-T Therapy
- Tumor Cell/Vascular Cell Interactions
- Vascular Biology
- VOD/SOS